Accelerating Drug Discovery for FTD RFP
Funds lead optimization and in vivo testing for frontotemporal dementia candidates, including medicinal chemistry and preclinical studies.
Accelerating Drug Discovery for FTD is a joint RFP from the Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD), targeting the lead optimization and in vivo testing stages of small molecule and biologic drug development for frontotemporal dementia. FTD — encompassing disorders caused by TDP-43, tau, FUS, and related pathologies — affects approxim…
Lead optimization (medchem refinement + in vitro ADME) and in vivo testing for FTD drug candidates. Small molecules and biologics only; target ID, validation, and screening excluded.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
Write proposalGrant Concept Note Example: Pre-Proposal Structure for Startups
See a practical grant concept note example, with a worked deeptech pre-proposal, section map, invite-to-full logic, and reviewer checks.
More from ADDF
All grants from this funder →ADDF Drug Development RFP
ADDF · Global / Multinational
Supports Alzheimer’s and dementia drug development from preclinical readiness to early clinical testing across diverse modalities.
ADDF Neuroimaging and CSF Biomarker RFP
ADDF · Global / Multinational
Funds new biomarkers for Alzheimer's and related dementias through PET ligands, MRI, spinal fluid, and brain activity measures.
ADDF Prevention RFP
ADDF · Global / Multinational
Supports dementia prevention research through precision risk reduction, combination treatment testing, and effectiveness comparisons.
ADDF-Harrington Scholar Program
🇺🇸ADDF · Global / Multinational
Funds academic Alzheimer's researchers with hit-to-lead and development-stage support plus therapeutic guidance.
Treat FTD Fund
ADDF · Global / Multinational
Funds early-stage clinical studies for frontotemporal dementia, including prevention trials for high-risk participants.
Similar grants
Browse the directory →
Parkinson's UK Drug Accelerator Awards
🇬🇧Parkinson's UK · United Kingdom
Funds translational Parkinson's drug discovery in the United Kingdom to generate partnership-ready preclinical evidence.
Deep Tech Accelerator (DTA)
🇫🇮Business Finland · Finland
Funds young Finnish deep-tech companies commercialising research results through a phased grant-and-loan package.
EIC Pre-Accelerator
🇧🇬EIC · European Union
Funds early-stage European deep-tech firms developing evidence-ready prototypes and proof-of-concept solutions.
Wellcome Discovery Awards
🇬🇧Wellcome · United Kingdom
Funds established United Kingdom investigators in bold health research with long-term flexible scientific support.
BARDA Accelerator Network — POC Funding
🇺🇸BARDA · United States
Funds proof-of-concept medical countermeasure projects across diagnostics, digital health, and therapeutic platforms.
Advancing innovation in accelerated cancer diagnosis
🇬🇧Innovate UK · United Kingdom
Supporting clinical validation of early cancer diagnostic technologies